Celsius Therapeutics is a biotechnology company that is developing a new approach to drug discovery and development. The company's platform uses single-cell genomics and machine learning to identify new drug targets and develop more effective therapies for a range of diseases, including cancer and autoimmune disorders. Celsius Therapeutics is focused on creating a new generation of precision medicines that are tailored to the unique genetic and molecular characteristics of individual patients.